Instillido

Lidocaine Hydrochloride, the active ingredient in Instillido, is a local anesthetic presented as a solution for urethral use. It provides temporary numbing of the urethral mucosa for diagnostic and therapeutic procedures. GNH USA supplies Instillido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Instillido, a lidocaine formulation, is applied to the urethral mucosa to facilitate painless urological procedures. - Cystoscopy: provides local anesthesia to reduce discomfort during visual examination of the bladder and urethra. - Urethral catheter insertion: numbs the urethra to allow smooth catheter placement with minimal pain. - Urethral dilation: eases the passage of dilators during treatment of strictures. - Transurethral procedures: offers temporary anesthesia for minor interventions such as biopsy or stent placement.

Instillido may cause a range of adverse reactions following urethral administration.

Common Side Effects: - Burning or stinging sensation at the application site. - Mild local irritation or redness. - Transient numbness lasting several minutes. - Light‑headedness or mild dizziness. - Headache. - Nausea.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling. - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias, including ventricular tachycardia. - Seizures or central nervous system toxicity. - Methemoglobinemia. - Respiratory depression.

When using Instillido, several safety considerations should be observed. - Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Dosage control: adhere strictly to prescribed volume to avoid systemic toxicity. - Patient monitoring: observe for signs of cardiovascular or neurologic adverse effects during and after administration. - Caution in cardiac disease: use carefully in patients with existing heart conduction abnormalities. - Avoid concurrent use of other local anesthetics to reduce cumulative toxicity risk. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Lidocaine can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid): - Other amide local anesthetics: increase risk of systemic toxicity. - Class I antiarrhythmics (e.g., quinidine, procainamide): may potentiate cardiac conduction disturbances. - CYP1A2 or CYP3A4 inhibitors (e.g., cimetidine, erythromycin): raise plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardic effects. - Diuretics (e.g., furosemide): can lower plasma protein binding, increasing free lidocaine. - Anticonvulsants: potential additive CNS depression. - Alcohol: may augment sedative properties. - Herbal supplements affecting CYP enzymes (e.g., St. John’s wort): alter lidocaine metabolism.